Repression of β-catenin signaling by PPARγ ligands
- 25 June 2010
- journal article
- Published by Elsevier BV in European Journal of Pharmacology
- Vol. 636 (1-3), 198-202
- https://doi.org/10.1016/j.ejphar.2010.03.010
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Functional Interaction between Peroxisome Proliferator-Activated Receptor γ and β-CateninMolecular and Cellular Biology, 2006
- The Many Faces of PPARγCell, 2005
- A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-γNature, 2005
- WNT and β-catenin signalling: diseases and therapiesNature Reviews Genetics, 2004
- Antineoplastic effects of peroxisome proliferatoractivated receptor γ agonistsThe Lancet Oncology, 2004
- Adenomatous Polyposis Coli (APC)-independent Regulation of β-Catenin Degradation via a Retinoid X Receptor-mediated PathwayPublished by Elsevier BV ,2003
- A Unique PPARγ Ligand with Potent Insulin-Sensitizing yet Weak Adipogenic ActivityMolecular Cell, 2001
- Involvement of p21WAF1/Cip1, p27Kip1, and p18INK4c in troglitazone-induced cell-cycle arrest in human hepatoma cell linesHepatology, 2001
- Inhibition of Cellular Proliferation through IκB Kinase-Independent and Peroxisome Proliferator-Activated Receptor γ-Dependent Repression of Cyclin D1Molecular and Cellular Biology, 2001
- PPARγ induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2AGenes & Development, 1997